Skip to main content

Table 2 Complications during study period and outcome related to troponin and copeptin values

From: The combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: a prospective observational study

  hsTnT ≤ 14 and Copeptin < 14 hsTnT > 14 or Copeptin ≥ 14 hsTnT > 14 and Copeptin ≥ 14 All
Total number of patients n = 204 n = 161 n = 113 n = 478
Complications     
Heartfailure demandning treatment 3 (2) 9 (6) 17 (15) 29 (6)
Major bleeding 2 (1) 3 (2) 7 (6) 12 (3)
Malign arrythmia 3 (2) 3 (2) 8 (7) 14 (3)
Outcome during hospital stay     
ACS 18 (9) 42 (26) 47 (42) 107 (22)
NSTEMI 3 (2) 30 (19) 37 (33) 70 (14)
Unstable angina pectoris 15 (7) 12 (7) 10 (9) 37 (8)
Coronary angiography with significant stenosis 18 (9) 35 (22) 36 (32) 89 (19)
Coronary angiography without significant stenosis 8 (4) 17 (11) 5 (4) 30 (6)
PCI 11 (5) 23 (14) 27 (24) 61 (13)
CABG 7 (3) 9 (6) 9 (8) 25 (5)
Cardiovascular death 0 (0) 0 (0) 1 (1) 1 (0,2)
Non cardiovascular death 0 (0) 0 (0) 4 (4) 4 (1)
Outcome after 60 days of follow up     
ACS during follow up, excluding hospital stay 1 (0,5) 4 (2) 4 (4) 9 (2)
Coronary angiography with significant stenosis during follow up 0 (0) 3 (2) 2 (2) 5 (1)
PCI during follow up 0 (0) 0 (0) 1 (1) 1 (0)
CABG during follow up 0 (0) 3 (2) 0 (0) 3 (0,5)
Death during follow up, excluding hospital stay 0 (0) 0 (0) 4 (4) 4 (1)
Combined endpoint 19 (9) 45 (28) 55 (49) 119 (25)
  1. ACS acute coronary syndrome, NSTEMI non ST-elevation myocardial infarction, PCI percutaneus coronary intervention, CABG coronary artery bypass grafting.
  2. Data presented as n (%) of patients. Complications are defined in methods. A combined endpoint of ACS, non-elective PCI, non-elective CABG and death of all causes was used.
  3. Troponin is presentetd in the unit ng/L and copeptin in pmol/L.